Mar. 18 at 3:20 AM
$CMND - Clearmind Medicine
🔹Announces Publication of Six Innovative Patents March 17, 2026
🔹In Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
🔹The 6 patents protect formulations combining PEA with MDMA, LSD, ketamine, ibogaine, psilocybin, and DMT
🔹Declared sourcing partnership with NeuroThera Labs for PEA
🔹Super Low Float of 1.5M shares
$VSME $MRLN